↓ Skip to main content

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection

Overview of attention for article published in Immunogenetics, September 2010
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
64 Dimensions

Readers on

mendeley
99 Mendeley
Title
Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection
Published in
Immunogenetics, September 2010
DOI 10.1007/s00251-010-0480-x
Pubmed ID
Authors

Nadia Wauquier, Cindy Padilla, Pierre Becquart, Eric Leroy, Vincent Vieillard

Abstract

Zaïre ebolavirus (ZEBOV) infection rapidly outruns the host's immunity and leads to death within a week. Fatal cases have been associated with an aberrant innate, proinflammatory immune response followed by a suppressed adaptive response leading to the rapid depletion of peripheral NK cells and lymphocytes. A critical role for NK cells has been suggested but not elucidated. In this genetic study, we investigated the association of KIR genotype with disease outcome by comparing genotypes of a Gabonese control population, IgG+ contacts, survivors, and fatalities of ZEBOV infection. We showed that the activating KIR2DS1 and KIR2DS3 genes associate with fatal outcome in Ebola virus infection. In addition, this study brings supplemental evidence in favor of the specificity of the IgG+ contact population. The outcome of fulminating Ebola virus infection could depend in part on the host's inherited KIR gene repertoire. This supports a key role for KIRs in disease susceptibility to infections.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 99 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 3%
South Africa 1 1%
Germany 1 1%
Nigeria 1 1%
United Kingdom 1 1%
Unknown 92 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 26 26%
Student > Ph. D. Student 16 16%
Student > Bachelor 10 10%
Student > Master 9 9%
Student > Doctoral Student 7 7%
Other 17 17%
Unknown 14 14%
Readers by discipline Count As %
Agricultural and Biological Sciences 29 29%
Biochemistry, Genetics and Molecular Biology 16 16%
Medicine and Dentistry 13 13%
Immunology and Microbiology 8 8%
Nursing and Health Professions 3 3%
Other 12 12%
Unknown 18 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2014.
All research outputs
#15,660,220
of 24,807,923 outputs
Outputs from Immunogenetics
#931
of 1,236 outputs
Outputs of similar age
#82,545
of 103,712 outputs
Outputs of similar age from Immunogenetics
#4
of 4 outputs
Altmetric has tracked 24,807,923 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,236 research outputs from this source. They receive a mean Attention Score of 4.1. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 103,712 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.